1289024-42-5 Usage
Uses
Used in Pharmaceutical Industry:
(5S,6S,9R)-6-(2,3-difluorophenyl)-9-(triisopropylsilyloxy)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-amine is used as a potential drug candidate for its unique molecular structure and specific functional groups. (5S,6S,9R)-6-(2,3-difluorophenyl)-9-(triisopropylsilyloxy)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-amine's chiral configuration and functional groups may offer novel therapeutic opportunities, and further research and development could explore its efficacy in treating various medical conditions.
Used in Chemical Synthesis:
In the chemical synthesis industry, (5S,6S,9R)-6-(2,3-difluorophenyl)-9-(triisopropylsilyloxy)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-amine may serve as a key intermediate in the synthesis of other bioactive compounds. Its unique structure and functional groups could be leveraged to create new molecules with potential applications in various fields, including pharmaceuticals, agrochemicals, and materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 1289024-42-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,8,9,0,2 and 4 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1289024-42:
(9*1)+(8*2)+(7*8)+(6*9)+(5*0)+(4*2)+(3*4)+(2*4)+(1*2)=165
165 % 10 = 5
So 1289024-42-5 is a valid CAS Registry Number.
1289024-42-5Relevant articles and documents
CGRP RECEPTOR ANTAGONISTS
-
Page/Page column 65, (2011/05/05)
The disclosure generally relates to the novel compounds of formula (I), including pharmaceutically acceptable salts, which are CGRP receptor antagonists. The disclosure also relates to pharmaceutical compositions and methods for using the compounds in the treatment of CGRP related disorders including migraine and other headaches, neurogenic vasodilation, neurogenic inflammation, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases such as asthma, and chronic obstructive pulmonary disease (COPD).
